Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB2244 - Provider product page
- Provider
- R&D Systems
- Product name
- Human CEACAM-1/CD66a Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. Detects human CEACAM-1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) CD31, rhICAM-1, -2, -3, recombinant mouse (rm) MAdCAM-1, or rhVCAM-1 was observed. In direct ELISAs, no cross-reactivity with rhCEACAM-6, -7, -8, and rmCEACAM-7 and less than 5% cross-reactivity with rhCEACAM-3, -5 was observed.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antigen sequence
P13688
- Isotype
- IgG
- Antibody clone number
- 283340
- Vial size
- 100 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references Nontypable Haemophilus influenzae displays a prevalent surface structure molecular pattern in clinical isolates.
Cytokine-induced CEACAM1 expression on keratinocytes is characteristic for psoriatic skin and contributes to a prolonged lifespan of neutrophils.
Martí-Lliteras P, López-Gómez A, Mauro S, Hood DW, Viadas C, Calatayud L, Morey P, Servin A, Liñares J, Oliver A, Bengoechea JA, Garmendia J
PloS one 2011;6(6):e21133
PloS one 2011;6(6):e21133
Cytokine-induced CEACAM1 expression on keratinocytes is characteristic for psoriatic skin and contributes to a prolonged lifespan of neutrophils.
Rahmoun M, Molès JP, Pedretti N, Mathieu M, Fremaux I, Raison-Peyron N, Lecron JC, Yssel H, Pène J
The Journal of investigative dermatology 2009 Mar;129(3):671-81
The Journal of investigative dermatology 2009 Mar;129(3):671-81
No comments: Submit comment
No validations: Submit validation data